Kevin Thomas Ferro

Kevin Thomas Ferro

Chief Executive Officer at
Ferro Holdings LLC (New York)
55 year
Health Technology
Finance
Consumer Services

Profile

Mr. Kevin T.
Ferro is a Chief Executive Officer at Ferro Holdings LLC (New York), a Founder, Chief Executive Officer at Vatera Healthcare Partners, a Chairman at Arisaph Pharmaceuticals, Inc. and a Chairman at ImmusanT, Inc. He is on the Board of Directors at Ekteino Laboratories, Inc. Mr. Ferro was previously employed as an Independent Director by Greenhill & Co., Inc., a Chairman by Melinta Therapeutics, Inc., a Chairman by Pearl Therapeutics, Inc., a Chief Executive & Investment Officer by Oikos Holdings LLC, a Chief Executive Officer & Investment Officer by Ferro Capital LLC, a Global Head-Alternative Investment Strategies by Commerzbank AG, and a Vice President by D.
E.
Shaw & Co. LP.
He also served on the board at KOS Pharmaceuticals, Inc., Eltrak SA and Melinta Subsidiary Corp.
He received his undergraduate degree from Harvard University.

Kevin Thomas Ferro active positions

CompaniesPositionStart
Chairman 01/01/2005
Chairman -
Director/Board Member -
Chief Executive Officer 01/08/2019

Former positions of Kevin Thomas Ferro

CompaniesPositionEnd
GREENHILL & CO., INC. Director/Board Member 30/11/2023
MELINTA THERAPEUTICS, INC. Chairman 05/08/2019
Chief Executive Officer 31/12/2018
Chairman 01/06/2013
Director/Board Member -
See the detail of Kevin Thomas Ferro's experience

Training of Kevin Thomas Ferro

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Finance

Health Technology

Finance

Consumer Services

Distribution Services

Finance

Health Technology

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Kevin Thomas Ferro
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!